Back to Search
Start Over
THE PRICE OF INSPIRATION.
- Source :
- Forbes; 9/5/2017, Vol. 200 Issue 2, p84-92, 5p, 1 Color Photograph, 1 Chart
- Publication Year :
- 2017
-
Abstract
- The article discusses the American pharmaceutical company Vertex Pharmaceuticals' development of an expensive drug to treat patients with cystic fibrosis (CF). An overview of the Vertex chief executive Jeffrey (Jeff) Leiden's role in changing Vertex's model of drug development, including in focusing on research and development (R&D) investment, is provided.
- Subjects :
- CYSTIC fibrosis treatment
DRUG prices
DRUG development
INVESTMENTS
FINANCE
Subjects
Details
- Language :
- English
- ISSN :
- 00156914
- Volume :
- 200
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Forbes
- Publication Type :
- Periodical
- Accession number :
- 124434259